eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | differentiated thyroid carcinoma |
| Symptom | C0029896|ent disease |
| Sentences | 7 |
| PubMedID- 24379008 | Objective: the aim of the study was to disclose the place of (18)f-fdg pet/ct to predict recurrent disease in patients with differentiated thyroid cancer (dtc), negative radioiodine whole-body scan (wbs) and high serum thyroglobulin (tg). |
| PubMedID- 21936380 | Serum thyroglobulin (tg) is primarily used as a tumor marker to detect the recurrent or persistent disease in patients with differentiated thyroid carcinomas. |
| PubMedID- 22496986 | Since, under normal conditions, thyroglobulin can only be found inside the thyroid gland, it has been used for decades as a sensitive tumor marker to detect persistent and recurrent disease in patients with differentiated thyroid cancer of follicular cell origin (the most common types of thyroid cancer). |
| PubMedID- 21085953 | Purpose: (131)i whole-body scan (wbs) and serum thyroglobulin (tg) are important in detecting thyroid remnants or recurrent disease in patients with differentiated thyroid cancer. |
| PubMedID- 22791600 | Fluorodeoxyglucose-positron emission tomography (fdg-pet)/computed tomography (ct) is able to localize persistent or recurrent disease in differentiated thyroid carcinoma (dtc). |
| PubMedID- 25287965 | Objectives: the aim of this study is to identify the prognostic factors predicting remission and subsequent disease relapse in patients with differentiated thyroid cancer (dtc) greater than 60years of age. |
| PubMedID- 20017617 | Conclusion: in the diagnosis of recurrent disease in patients with differentiated thyroid carcinoma and low tg level, the sensitivity of rhtsh-stimulated pet/ct-fdg seems to be low and no correlation was observed between pet/ct-fdg findings and tg level. |
Page: 1